Osteoclastogenesis Responds to STING Inhibition in a Non‐Monotonic Manner
The FASEB Journal · 2026
DOI: 10.1096/fj.202502905rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Liangjie Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Membrane Proteins, Osteoclasts, Osteogenesis, Osteoporosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.
Abstract (Originalsprache)
Recent studies have indicated the paradoxical roles of stimulator of interferon genes (STING) in bone metabolism, which obscures targeting STING to treat osteoporosis. Here, by integrating ovariectomy (OVX)‐induced osteoporosis models, osteoblast‐specific Sting knockout mice, and staged in vitro osteoclastogenesis models, we report that STING temporally regulates osteoclast differentiation without participating in osteoblast‐mediated bone homeostasis. Through the timed administration of the STING inhibitor C‐176, we found a non‐monotonic bone response to STING inhibition in OVX mice. Early intervention was found to significantly increase bone mass, while therapeutic efficacy progressively decreased in later stages, with intervention at the terminal stage exacerbating bone loss. Furthermore, osteoblast‐specific Sting knockout mice showed no change in bone mass whether in the static state or after OVX. In vitro assays revealed that the STING downstream temporal partitioning of nuclear factor kappa‐B (NF‐κB) and interferon (IFN) pathways bidirectionally dictated osteoclast differentiation. Activation of the NF‐κB pathway drove cell fate commitment, whereas activation of the IFN pathway inhibited multinuclear maturation. Moreover, polymerase chain reaction array and transcriptomic analyses supported the stage‐specific activation of NF‐κB and IFN pathways during both human and murine osteoclastogenesis. Collectively, these findings establish a critical early therapeutic window for STING inhibition and highlight a timed strategy to maximize osteoprotective efficacy while avoiding adverse outcomes in osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
- Department of Orthopedics, No. 954 Hospital of the Army, Shannan, China.
- Institute of Medical Research, Northwestern Polytechnical University, Xi'an, China.
- College of Life Sciences, Northwest University, Xi'an, China.
- Department of Orthopedics, No. 989 Hospital of Joint Logistics Support Force, Luoyang, China.
- Department of Biomedical Engineering, Faculty of Engineering, The Chinese University of Hong Kong, Hong Kong, SAR, China.
ORCID-Profile: Liangjie Huang, Zhong Alan Li, Liu Yang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Huang, L., Lu, W., Liu, H., Hu, J., Fan, J., Song, S., Cao, G., Ding, G., He, T., Li, Z. A., Yang, L., & Zheng, C. (2026). Osteoclastogenesis Responds to STING Inhibition in a Non‐Monotonic Manner. The FASEB Journal. https://doi.org/10.1096/fj.202502905rr
Vancouver
Huang L, Lu W, Liu H, Hu J, Fan J, Song S, et al. Osteoclastogenesis Responds to STING Inhibition in a Non‐Monotonic Manner. The FASEB Journal. 2026. doi:10.1096/fj.202502905rr
BibTeX
@article{Huang2026,
author = {Huang, Liangjie and Lu, Weiguang and Liu, He and Hu, Jingyan and Fan, Jing and Song, Shiju and Cao, Guoqing and Ding, Guangyu and He, Ting and Li, Zhong Alan and Yang, Liu and Zheng, Chao},
title = {Osteoclastogenesis Responds to STING Inhibition in a Non‐Monotonic Manner},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202502905rr}
}
EUVIMED